Statement on Chairma
Statement on Chairman Glenn Thompson's 'Corrupt' House Farm Bill Released Today
May 17, 2024 16:58 ET | Competitive Markets Action
WASHINGTON, D.C., May 17, 2024 (GLOBE NEWSWIRE) -- Today, the Organization for Competitive Markets and Competitive Markets Action released the following statement in response to U.S. House Committee...
KTMC-Logo_RGB.jpg
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors with Losses to Contact the Firm
May 17, 2024 16:48 ET | Kessler Topaz Meltzer & Check LLP
RADNOR, Pa., May 17, 2024 (GLOBE NEWSWIRE) --  The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the...
KASKELA LAW LOGO1.jpg
MERGER INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Avangrid, Inc. (AGR) and Encourages Investors to Contact the Firm
May 17, 2024 16:42 ET | Kaskela Law
PHILADELPHIA, May 17, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Avangrid, Inc. (NYSE: AGR) on behalf of the company’s shareholders. On May 17, 2024, Avangrid...
exgen.png
ExGen: Phoenix Raises US$80 Million for Construction of the Empire Mine, Idaho
May 17, 2024 16:35 ET | ExGen Resources Inc
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- ExGen Resources Inc. (TSX.V: EXG;...
AthenaDexFi logo.PNG
Breaking News: AthenaDexFi Launches Exciting Pre-Sale for ATH Token, Unveiling Lucrative Investment Opportunities with Airdrop Bonus
May 17, 2024 16:35 ET | AthenaDexFi
Saint Vincent e Grenadine, Caribbean, May 17, 2024 (GLOBE NEWSWIRE) -- In an ever-evolving investment landscape, AthenaDexFi emerges as a beacon of innovation, offering investors a diverse array of...
briacell-logo-square-a.jpg
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
May 17, 2024 16:33 ET | BriaCell Therapeutics Corp.
PHILADELPHIA and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...
Oculis logo.png
Oculis updates share capital for its existing at-the-market offering program
May 17, 2024 16:30 ET | Oculis Holding AG
ZUG, May 17, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company, has issued registered ordinary shares of the...
ultragenyx-CMYK.png
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024 16:30 ET | Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
Nuvini (Nasdaq: NVNI) Announces Nasdaq Notification of Non-Compliance Regarding Delayed Form 20-F Filing
May 17, 2024 16:30 ET | Nvni Group Limited
Nvni Group Limited announced that it received a notice from Nasdaq indicating the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1).
DZS-Dark-Blue.jpg
DZS Inc. Receives Expected Nasdaq Notice Regarding Late Form 10-Q Filing
May 17, 2024 16:30 ET | DZS
DZS Inc. Receives Expected Nasdaq Notice Regarding Late Form 10-Q Filing